Posted in | News | Nanoenergy | Nanobusiness

DelSolar Enters Second Agreement with Wafer Supplier GCL-Poly

DelSolar Co., Ltd. (3599.TW) announced today that it has signed a second long-term wafer supply contract with GCL (Nanjing) Solar Energy Technology Company Limited, a wholly-owned subsidiary of GCL-Poly Energy Holdings Limited (3800.HK), further strengthening the long-term strategic alliance between the two companies. GCL-Poly is one of the world‟s leading polysilicon and wafer suppliers.

GCL-Poly will provide to DelSolar high quality wafers that can meet the needs of about 664MW cells from October 2010 to December 2015. The agreement includes a mechanism by which the parties may adjust prices to better reflect prevailing market conditions. DelSolar expects the alliance to greatly enhance its overall operational needs and profitability.

R.C. Liang, Chairman and CEO of DelSolar said, „„Both companies have been performing very well in meeting their obligations since signing the first wafer supply contract in May, 2010. In order to strengthen our strategic partnership with GCL-Poly and to secure the material needs for DelSolar‟s future expansion, we have proactively discussed the second long-term supply contract with GCL-Poly. DelSolar was pleased to quickly reach agreement on the second supply contract with GCL-Poly. This agreement will enhance DelSolar‟s market position and strengthen the strategic partnership between both companies.”

Mr. Zhu Gong Shan, Executive Director, Chairman and CEO of GCL-Poly, said, “We are delighted to be able to sign the second wafer supply agreement with DelSolar, a leading solar company in Taiwan, so soon after we signed the first wafer supply contract. This demonstrates again the endorsement and recognition of GCL-Poly‟s products and customer services by leading industry players. I look forward to closer cooperation with Delsolar in the future, thus creating a win-win situation for both companies within the fast-growing solar industry."

Source: http://www.delsolarpv.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.